SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-16-700896
Filing Date
2016-09-02
Accepted
2016-09-02 16:30:50
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d241493ds3.htm S-3 301703
2 EX-5.1 d241493dex51.htm EX-5.1 5422
3 EX-23.2 d241493dex232.htm EX-23.2 1535
4 GRAPHIC g241493bcpg01.jpg GRAPHIC 7947
5 GRAPHIC g241493covpg01.jpg GRAPHIC 7914
6 GRAPHIC g241493g10a41.jpg GRAPHIC 50063
  Complete submission text file 0001193125-16-700896.txt   401047
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-213493 | Film No.: 161869018
SIC: 2834 Pharmaceutical Preparations